(Q34566620)

3 August 2017

title

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys (English)

1 reference

3 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662477

23 October 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300513

23 October 2022

author

J. Timothy Greenamyre

object named as

J. T. Greenamyre

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662477

23 October 2022

D. M. Gash

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662477

23 October 2022

Honoré T

1 reference

3 August 2017

T. Klockgether

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662477

23 October 2022

L. Turski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662477

23 October 2022

T. Honoré

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662477

23 October 2022

Z. M. Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662477

23 October 2022

R. Kurlan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662477

23 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1662477

23 October 2022

publication date

1 November 1991

1 reference

full work available at URL

3 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410300513

1 reference

DOI

https://api.crossref.org/works/10.1002/ANA.410300513

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410300513

23 October 2022

1 reference

DOI

https://api.crossref.org/works/10.1002/ANA.410300513

23 October 2022

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

717-723

1 reference

The functional anatomy of basal ganglia disorders

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Somatosensory thresholds in monkeys exposed to acrylamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300513

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/ANA.410300513

Pharmacological study of the cortical-induced excitation of subthalamic nucleus neurons in the rat: evidence for amino acids as putative neurotransmitters

23 October 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300513

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

23 October 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300513

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

23 October 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300513

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

23 October 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300513

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia

23 October 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300513

23 October 2022

Identifiers

DOI

1 reference

3 August 2017

1 reference